新闻中心 - GERBU中国区代理商/公司/官网

欢迎来到 GERBU中国区代理商/公司/官网

全国咨询热线： 18771149750

GERBU中国区代理商/公司/官网

产品中心

推荐产品

invivoCrown IV0110替换BioXCell BE0058

invivoCrown IV0119替换BioXCell BE0004-1

联系我们

地址：武汉市洪山区光谷大道35号光谷总部国际时代二期1栋1301

电话：15172431432

传真：18327026838

邮箱：sales@amyjet.com

新闻中心

首页 > 新闻中心

艾美捷科技代理Affinity Immuno品牌。

Affinity Immuno（AffinityImmuno）是一家位于加拿大的生物技术公司，一直专注于为生物药物研究提供高质量的试剂和服务。该公司以其专业的技术背景和丰富的产品线，在生物仿制药和单抗药研究领域赢得了广泛的认可，广泛应用于学术研究、生物技术和制药公司的研究工作。

AffinityImmuno产品包括：

（1）ELISA试剂盒：

AffinityImmuno生产的ELISA试剂盒具有高灵敏度、特异性和可重复性，用于测定临床前和临床血清血浆样本中的抗体药浓度，以及进行免疫学相关检测。这些试剂盒可用于检测多种疾病，如癌症、自身免疫病和感染病等。

（2）抗体：

公司提供多种抗体产品，包括针对癌症、自身免疫和内分泌疾病的新型靶点的抗体，以及用于细胞去除、阻断和激活研究的单克隆抗体。AffinityImmuno还可根据客户要求进行定制化开发，如多克隆抗体的制备。

（3）研发支持服务：

除了产品销售外，AffinityImmuno还提供高质量的研发支持服务，包括抗体发现、蛋白质工程和检测开发等。这些服务旨在帮助客户加速生物药物的研发进程，提高研发效率和质量。

<<< " data-original="http://gerbu.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Affinity Immuno品牌"> 艾美捷科技代理Affinity Immuno品牌

...

阅读详情

Premetek公司致力于为学术客户和工业客户提供化学试剂、纳米材料和催化剂，同时也提供多领域的研发服务。通过不断地与业内专业企业进行技术整合，Premetek不断更新产品，并为材料科学和催化领域提供了最多样化和可扩展的选择。

Our retail objectives are to offer the most expansive selection of premium products, provide easy and friendly service, offer the fastest delivery time possible, and ensure that every customer is satisfied with their purchase. Our inventory is determined by extensive market research, attendance at international tradeshows and conferences, customer feedback, and working closely with industry experts and vendors. Premetek is committed to continually improving our services and being the premier online market place for all your needs.

Premetek公司的主要产品包括：

Nanomaterials

Nanomaterial Suspension

Pt,Pd Catalysts -Hydrogenation

Pt,Pd Catalysts -Red/Oxidation

Pt Catalysts - Electrochemistry

Pt Alloy Catalysts - Electrochemistry

Pd Alloy Catalysts - Electrochemistry

Pd,Ru,Ir,Rh,Au Catalysts - Electrochemistry

Fe,Co,Ni,Cu,Ag Catalysts - Electrochemistry

Pt,Pd,Ru,Ir,Rh,Au-Organometallics

Pt, Pd, Rh Homogeneous Catalysts

Custom Products

Special catalysts in stock

品名	货号	规格
Aluminum titanate, Al2TiO5, 40 g each	N10A1000	40g
Barium strontium titanium oxide, BaSrTi2O6, 40 g each	N10B2000	40g
Calcium titanate, CaTiO3, 40 g each	N10C1000	40g
Calcium zirconium titanium oxide, CaZrTi2O3, 40 g each	N10C2000	40g
Cadmium tungsten oxide, CdWO4, 40 g each	N10C3000	40g
Cerium aluminate, CeAlO3, 40 g each	N10C4000	40g
Copper aluminate, CuAl2O4, 40 g each	N10C5000	40g
Iron nickel oxide, FeNiO4, 40 g each	N10I1000	40g
Lanthanum chromite, LaCrO3, 40 g each	N10L1000	40g
Lanthanum manganite , LaMnO3, 40 g each	N10L3000	40g
Lanthanum substituted lithium titanate, (LaLi3)TiO3, 40 g each	N10L5000	40g
Lead zirconium substituted titanate, PbZr0.2Ti0.8O3, 40 g each	N10L6000	40g
Manganese titanate, MnTiO3, 40 g each	N10M1000	40g
Magnesium aluminate, MgAl2O4, 40 g each	N10M2000	40g
Nickel cobalt oxide, NiCoO2, 40 g each	N10N1000	40g
Strontium bismuth niobium oxide, SrBi2Nb2O9, 50 g each	N10S1000	40g
Strontium ferrite, SrFe12O19, 40 g each	N10S2000	40g
Yttrium aluminum oxide, Y3Al5O12, 40 g each	N10Y1000	40g
Yttrium iron oxide, Y3Fe5O12, 40 g each	N10Y2000	40g
Zinc iron oxide, ZnFe2O4, 40 g each	N10Z1000	40g
Zinc titanium oxide, ZnTiO3, 40 g each	N10Z2000	40g
Concentrated Suspension of Nanoscaled Titanium Dioxide (TiO2), 5 kg	N-1000	5kg
Concentrated Suspension of Nanoscaled Zinc Oxide (ZnO), 5 kg	N-2000	5kg
Concentrated Suspension of Nanoscaled Zinc Oxide (ZnO), 5 kg	N-2010	5kg
Suspension of Nanoscaled Iron Oxide (Fe2O3), 5 kg	N-3000	5kg
Concentrated Suspension of Nanoscaled Iron Oxide (Fe2O3), 5 kg	N-3010	5kg
Concentrated Suspension of Nanoscaled Iron Oxide (Fe2O3), 5 kg	N-3020	5kg
Concentrated Suspension of Nanoscaled Iron Oxide (Fe2O3), 5 kg	N-3130	5kg
Concentrated Suspension of Nanoscaled Iron Oxide (Fe2O3), 5 kg	N-3220	5kg
Concentrated Suspension of Nanoscaled Iron Oxide (Fe2O3), 5 kg	N-3230	5kg
0.1% Pt on activated carbon powder, 10 g each	P10J1001	10g
0.5% Pt on activated carbon powder, 10 g each	P10J1005	10g
1.0% Pt on activated carbon powder, 10 g each	P10J1010	10g
5.0% Pt on activated carbon powder, 10 g each	P10J1050	10g
10% Pt on activated carbon powder, 10 g each	P10J1100	10g
20% Pt on activated carbon powder, 10 g each	P10J1200	10g
0.1% Pt on granular carbon, 10 g each	P10J2001	10g
0.5% Pt on granular carbon, 10 g each	P10J2005	10g
1.0% Pt on granular carbon, 10 g each	P10J2010	10g
5.0% Pt on granular carbon, 10 g each	P10J2050	10g
0.1% Pd on activated carbon powder, 10 g each	P30J1001	10g
0.5% Pd on activated carbon powder, 10 g each	P30J1005	10g
1.0% Pd on activated carbon powder, 10 g each	P30J1010	10g
5.0% Pd on activated carbon powder, 10 g each	P30J1050	10g
10% Pd on activated carbon powder, 10 g each	P30J1100	10g
20% Pd on activated carbon powder, 10 g each	P30J1200	10g
0.1% Pd on granular carbon, 10 g each	P30J2001	10g
0.3% Pd on granular carbon, 10 g each	P30J2003	10g
0.5% Pd on granular carbon, 10 g each	P30J2005	10g
1.0% Pd on granular carbon, 10 g each	P30J2010	10g
5.0% Pd on granular carbon, 10 g each	P30J2050	10g
0.5% Pd on alumina spheres, 3 mm, SA=	P30L1005	10g
1.0% Pd on alumina spheres, 3 mm, SA=	P30L1010	10g
0.1% Pt on alumina powder, 10 g each	P10K1001	10g
0.5% Pt on alumina powder, 10 g each	P10K1005	10g
1.0% Pt on alumina powder, 10 g each	P10K1010	10g
5.0% Pt on alumina powder, 10 g each	P10K1050	10g
10% Pt on alumina powder, 10 g each	P10K1100	10g
20% Pt on alumina powder, 10 g each	P10K1200	10g
0.1% Pd on alumina powder, 10 g each	P30K1001	10g
0.5% Pd on alumina powder, 10 g each	P30K1005	10g
1.0% Pd on alumina powder, 10 g each	P30K1010	10g
5.0% Pd on alumina powder, 10 g each	P30K1050	10g
10% Pd on alumina powder, 10 g each	P30K1100	10g
20% Pd on alumina powder, 10 g each	P30K1200	10g
5% Pt on Vulcan XC-72	P10A050	1g/5g
10% Pt on Vulcan XC-72	P10A100	1g/5g
20% Pt on Vulcan XC-72	P10A200	1g/5g
30% Pt on Vulcan XC-72	P10A300	1g/5g
40% Pt on Vulcan XC-72	P10A400	1g/5g
50% Pt on Vulcan XC-72	P10A500	1g/5g
60% Pt on Vulcan XC-72	P10A600	1g/5g
80% Pt on Vulcan XC-72	P10A800	1g/5g
Pt Black, High surface area: 40-50 m2/g, Low density: 0.6-0.9 g/ml	P10V010	1g/5g
20% Pt on Durable Carbon	P10D200	1g/5g
20% Pt on Vulcan XC-72R	P10B200	1g/5g
40% Pt on Vulcan XC-72R	P10B400	1g/5g
60% Pt on Vulcan XC-72R	P10B600	1g/5g
40% Pt on high surface area Ketjenblack	P10E400	1g/5g
50% Pt on high surface area Ketjenblack,	P10E500	1g/5g
60% Pt on high surface area Ketjenblack	P10E600	1g/5g
70% Pt on high surface area Ketjenblack	P10E700	1g/5g
5% Pt-Ru (1:1 atomic ratio) on Vulcan XC-72	P12A050	1g/5g
10% Pt-Ru (1:1 atomic ratio) on Vulcan XC-72	P12A100	1g/5g
20% Pt-Ru (1:1 atomic ratio) on Vulcan XC-72	P12A200	1g/5g
30% Pt-Ru (1:1 atomic ratio) on Vulcan XC-72	P12A300	1g/5g
40% Pt-Ru (1:1 atomic ratio) on Vulcan XC-72	P12A400	1g/5g
50% Pt-Ru (1:1 atomic ratio) on Vulcan XC-72	P12A500	1g/5g
60% Pt-Ru (1:1 atomic ratio) on Vulcan XC-72R	P12B600	1g/5g
60% Pt-Ru (1:1 atomic ratio) on Vulcan XC-72	P12A600	1g/5g
80% Pt-Ru (1:1 atomic ratio) on Vulcan XC-72	P12A800	1g/5g
Pt-Ru Black (1:1 atomic ratio)	P12V010	1g/5g
Pt-Ru Black (2.5:1 atomic ratio)	P12V250	1g/5g
Pt-Ru-Ir Black (1:1:1 atomic ratio)	P124V010	1g/5g
50% Pt-Ru (1:1 atomic ratio) on Ketjenblack	P12E500	1g/5g
60% Pt-Ru (1:1 atomic ratio) on Ketjenblack	P12E600	1g/5g
75% Pt-Ru (1:1 atomic ratio) on Ketjenblack	P12E750	1g/5g
20% Pt-Pd (1:3 atomic ratio) on Vulcan XC-72	P13A203	1g/5g
20% Pt-Pd (1:1 atomic ratio) on Vulcan XC-72	P13A200	1g/5g
20% Pt-Pd (3:1 atomic ratio) on Vulcan XC-72	P13A230	1g/5g
40% Pt-Pd (1:1 atomic ratio) on Vulcan XC-72	P13A400	1g/5g
Pt-Pd Black (1:1 atomic ratio)	P13V010	1g/5g
Pt-Rh Black (1:1 atomic ratio)	P15V010	1g/5g
20% Pt-Ir (1:3 atomic ratio) on Vulcan XC-72	P14A203	1g/5g
20% Pt-Ir (1:1 atomic ratio) on Vulcan XC-72	P14A200	1g/5g
20% Pt-Ir (3:1 atomic ratio) on Vulcan XC-72	P14A230	1g/5g
40% Pt-Ir (1:1 atomic ratio) on Vulcan XC-72	P14A400	1g/5g
Pt-Ir Black (1:1 atomic ratio)	P14V010	1g/5g
20% Pt-Cr (3:1 atomic ratio) on Vulcan XC-72	P1AA230	1g/5g
40% Pt-Cr (3:1 atomic ratio) on Vulcan XC-72	P1AA430	1g/5g
20% Pt-Fe (1:1 atomic ratio) on Vulcan XC-72	P1BA200	1g/5g
40% Pt-Fe (1:1 atomic ratio) on Vulcan XC-72	P1BA400	1g/5g
40% Pt-Fe (3:1 atomic ratio) on Vulcan XC-72	P1BA430	1g/5g
20% Pt-Co (1:1 atomic ratio) on Vulcan XC-72	P1CA200	1g/5g
20% Pt-Co (3:1 atomic ratio) on Vulcan XC-72	P1CA230	1g/5g
40% Pt-Co (1:1 atomic ratio) on Vulcan XC-72	P1CA400	1g/5g
40% Pt-Co (3:1 atomic ratio) on Vulcan XC-72	P1CA430	1g/5g
60% Pt-Co (3:1 atomic ratio) on Ketjenblack	P1CE630	1g/5g
20% Pt-Ni (1:1 atomic ratio) on Vulcan XC-72	P1DA200	1g/5g
20% Pt-Ni (3:1 atomic ratio) on Vulcan XC-72	P1DA230	1g/5g
40% Pt-Ni (1:1 atomic ratio) on Vulcan XC-72	P1DA400	1g/5g
40% Pt-Ni (3:1 atomic ratio) on Vulcan XC-72	P1DA430	1g/5g
60% Pt-Ni (3:1 atomic ratio) on Ketjenblack	P1DE630	1g/5g
20% Pt-Cu (1:1 atomic ratio) on Vulcan XC-72	P1EA200	1g/5g
20% Pt-Cu (3:1 atomic ratio) on Vulcan XC-72	P1EA230	1g/5g
20% Pt-Sn (3:1 atomic ratio) on Vulcan XC-72	P1FA230	1g/5g
40% Pt-Sn (3:1 atomic ratio) on Vulcan XC-72	P1FA430	1g/5g
20% Pd-Ir (1:3 atomic ratio) on Vulcan XC-72	P34A203	1g/5g
20% Pd-Ir (1:1 atomic ratio) on Vulcan XC-72	P34A200	1g/5g
20% Pd-Ir (3:1 atomic ratio) on Vulcan XC-72	P34A230	1g/5g
20% Pd-Rh (1:1 atomic ratio) on Vulcan XC-72	P35A200	1g/5g
20% Pd-Rh (3:1 atomic ratio) on Vulcan XC-72	P35A230	1g/5g
20% Pd-Ni (1:1 atomic ratio) on Vulcan XC-72	P3DA200	1g/5g
40% Pd-Au (1:1 atomic ratio) on Ketjenblack	P13E400	1g/5g
5% Pd on Vulcan XC-72	P30A050	1g/5g
10% Pd on Vulcan XC-72	P30A100	1g/5g
20% Pd on Vulcan XC-72	P30A200	1g/5g
40% Pd on Vulcan XC-72	P30A400	1g/5g
40% Pd on Ketjenblack	P30E400	1g/5g
60% Pd on Vulcan XC-72	P30A600	1g/5g
80% Pd on Vulcan XC-72	P30A800	1g/5g
Pd Black, High surface area 40~48 m2/g	P30V010	1g/5g
20% Ru on Vulcan XC-72	P20A200	1g/5g
40% Ru on Vulcan XC-72,	P20A400	1g/5g
Ru Black, High surface area 38~48 m2/g	P20V010	1g/5g
RuO2 powder, Surface area 18-25 m2/g	P20V020	1g/5g
5% Ir on Vulcan XC-72	P40A050	1g/5g
10% Ir on Vulcan XC-72	P40A100	1g/5g
20% Ir on Vulcan XC-72	P40A200	1g/5g
40% Ir on Vulcan XC-72	P40A400	1g/5g
Ir Black, High Surface area, 55~65 m2/g,	P40V010	1g/5g
IrOx powder, conductive, SA:10-20 m2/g	P40V020	1g/5g
Ru-Ir Black (1:1 atomic ratio)	P24V010	1g/5g
20% Rh on Vulcan XC-72	P50A200	1g/5g
Rh Black, High surface area 40~50 m2/g	P50V010	1g/5g
20% Au on Vulcan XC-72 (Au particle size: 4-8 nm)	P60N200	1g/5g
20% Au on Vulcan XC-72 (Au particle size: ~25 nm)	P60A200	1g/5g
30% Au on Vulcan XC-72 (Au particle size: 8 nm)	P60N300	1g/5g
40% Au on Vulcan XC-72 (Au particle size: ~35 nm)	P60A400	1g/5g
40% Au on Ketjenblack (Au particle size: 4 nm)	P60E400	1g/5g
60% Au on Vulcan XC-72 (Au particle size: ~45 nm)	P60A600	1g/5g
5% Fe on Vulcan XC-72	T10A050	1g/5g
10% Fe on Vulcan XC-72	T10A100	1g/5g
20% Fe on Vulcan XC-72	T10A200	1g/5g
1% Co on Vulcan XC-72	T20A010	1g/5g
5% Co on Vulcan XC-72	T20A050	1g/5g
10% Co on Vulcan XC-72	T20A100	1g/5g
20% Co on Vulcan XC-72	T20A200	1g/5g
1% Ni on Vulcan XC-72	T30A010	1g/5g
5% Ni on Vulcan XC-72	T30A050	1g/5g
10% Ni on Vulcan XC-72	T30A100	1g/5g
20% Ni on Vulcan XC-72	T30A200	1g/5g
40% Ni on Vulcan XC-72	T30A400	1g/5g
1% Cu on Vulcan XC-72	T40A010	1g/5g
5% Cu on Vulcan XC-72	T40A050	1g/5g
10% Cu on Vulcan XC-72	T40A100	1g/5g
20% Cu on Vulcan XC-72	T40A200	1g/5g
40% Cu on Vulcan XC-72	T40A400	1g/5g
60% Cu on Vulcan XC-72	T40A600	1g/5g
20% Ag on Vulcan XC-72	P70A200	1g/5g
40% Ag on Vulcan XC-72	P70A400	1g/5g
60% Ag on Vulcan XC-72	P70A600	1g/5g
80% Ag on Vulcan XC-72	P70A800	1g/5g
Platinum (II) acetylacetonate, 5 g each	P10H110	5g
(1,5-Cyclooctadiene)dimethylplatinum(II), 1 g each	P10H120	1g
Dichloro(1,5-cyclooctadiene)platinum(II), 5 g each	P10H130	5g
Diphenyl(1,5-cyclooctadiene)platinum(II), 5 g each	P10H140	5g
Trimethylbenzylammoniumhexachloroplatinate (IV), 1 g each	P10H150	1g
Palladium(II) acetylacetonate, 5 g each	P30H110	5g
Dichloro(1,5-cyclooctadiene)palladium(II), 5 g each	P30H120	5g
Hermann's Catalyst, 5 g each	P30H130	5g
1,1'-Bis(di-tert-butylphosphino)ferrocene palladium dichloride, 1 g each	P30H140	1g
Bis(dibenzylideneacetone)palladium(0), 5 g each	P30H150	5g
Palladium(0) tetrakis(triphenylphosphine), 5 g each	P30H160	5g
Ruthenium(III) acetylacetonate, 5 g each	P20H110	5g
Dichloro(1,5-cyclooctadiene)ruthenium(II), polymer, 5 g each	P20H120	5g
Bis(cyclopentadienyl)ruthenium, 5 g each	P20H130	5g
Irridium(III) acetylacetonate, 5 g each	P40H110	5g
Chloro(1,5-cyclooctadiene)iridium(I) dimer, 5 g each	P40H120	5g
Rhodium(III) acetylacetonate, 5 g each	P50H110	5g
Chloro(1,5-cyclooctadiene)rhodium(I) dimer, 1 g each	P50H120	1g
Chloro(triphenylphosphine)gold(I), 5 g each	newitem3	5g
Bromo(triphenylphosphine)gold(I), 5 g each	P60H110	5g
Chloro(1,5-cyclooctadiene)rhodium(I) dimer, 98% 1 g	P50-002	1g
Chloro(1,5-cyclooctadiene)rhodium(I) dimer, 98% 1 g	P50-002	1g
Doyledirhodium catalyst-Rh2(5R-MPPIM)4, 1 g	P50-001	1g
Doyledirhodium catalyst-Rh2(5S-MPPIM)4, 1 g	P50-003	1g

更多详情请联系

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

" data-original="http://gerbu.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Premetek"> Premetek

...

阅读详情

Santa Cruz Biotechnology公司是全球最大的抗体生产厂商之一，目前公司提供二万余种研究用的第一抗体，几乎覆盖了目前生命科学研究的各个最新领域，其每种抗体又有多个克隆可以选择，还提供一些对应蛋白标准品及相关产品，如ABC试剂盒，各种标记二抗，Western试剂盒，蛋白分子量Marker，核抽提物等，为免疫学研究工作提供了极大的方便。

更多详情请联系

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

" data-original="http://gerbu.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Santa Cruz Biotechnology"> Santa Cruz Biotechnology

...

阅读详情

Salimetrics是一家全球著名的唾液生物学研究领域专业产品供应商，其在唾液的收集方法、生物学性质及其（唾液中各生物组分的含量）定量检测技术拥有绝对的研发与产品供应优势。作为唾液生物学研究及诊断试剂盒应用领域的行业标准，其供应的唾液手机方案及唾液成分的ELISA检测试剂盒均专门唾液的理化性质所设计，可确保客户在科学研究或临床诊断中得到稳定、准确的唾液生物学信息，并同时具有操作简便、结果精确可靠、可重复性高、耗时少等诸多优点。Salimetrics的唾液检测实验室及拥有丰富的唾液生物学研发经验的专业团队可以为广大客户提供唾液生物学研究及诊断应用的专业指导。

更多详情请联系

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

产品名称	产品编号	产品参数
Salivary 17 Alpha-OHP ELISA Kit	1-2602	Catalog#: 1-2602 Format: 96-well plate Assay Time: ~ 3 hrs Sample Volume/Test: 50 µL Sensitivity: 3 pg/mL Assay Range: 5.1 pg/mL - 500pg/mL Storage Requirements: 2-8°C Optimum Collection Volume: 125 μL* Collect With: SalivaBio Passive Drool Serum-Saliva Correlation: 0.64
Salivary Alpha-Amylase Enzymatic Kit	1-1902	Catalog#:1-1902 Format:96-well plate Assay Time:~ 30 mins Sample Volume/Test:10 µL of saliva then 8 µL of X200 dilution Sensitivity:0.4 U/mL Assay Range:2-400 U/mL Storage Requirements:2-8°C Optimum Collection Volume:25 μL* Collect With:SalivaBio Passive Drool SalivaBio Oral Swab (SOS) SalivaBio Children's Swab (SCS) SalivaBio Infant's Swab (SIS) Serum-Saliva Correlation:NA
Salivary Androstenedione ELISA Kit	1-2902	Catalog#:1-2902 Format:96-well plate Assay Time:~ 3 hrs Sample Volume/Test:50 µL Sensitivity:5 pg/mL Assay Range:10 pg/mL - 2430 pg/mL Storage Requirements:2-8°C Optimum Collection Volume:125 μL* Collect With:SalivaBio Passive Drool Serum-Saliva Correlation:NA
Salivary C-Reactive Protein ELISA Kit	1-2102	Catalog#:1-2102 Format:96-well plate Assay Time:~ 5 hrs Sample Volume/Test:150 µL of saliva, 100 µL of x2 dilution Sensitivity:9.72 pg/mL Assay Range:25 pg/mL - 1600 pg/mL Storage Requirements:2-8°C Optimum Collection Volume:225 μL* Collect With:SalivaBio Passive Drool Serum-Saliva Correlation:NA
Salivary Cortisol ELISA Kit	1-3002	Catalog#:1-3002 Format:96-well plate Assay Time:~ 2 hrs Sample Volume/Test:25 µL Sensitivity:<0.007 ug/dL Assay Range:0.012-3.000 ug/dL Storage Requirements:2-8°C Optimum Collection Volume:75 uL Collect With:SalivaBio Passive Drool SalivaBio Oral Swab (SOS) SalivaBio Children's Swab (SCS) SalivaBio Infant's Swab (SIS) Serum-Saliva Correlation:0.91
Salivary Cotinine ELISA Kit	1-2002	Catalog#:1-2002 Format:96-well plate Assay Time:~ 2.5 hrs Sample Volume/Test:20 µL Sensitivity:0.15 ng/mL Assay Range:0.8 ng/mL - 200 ng/mL Storage Requirements:2-8°C Optimum Collection Volume:75 µL* Collect With:SalivaBio Passive Drool SalivaBio Oral Swab (SOS) SalivaBio Children's Swab (SCS) SalivaBio Infant's Swab (SIS) Serum-Saliva Correlation:NA
Salivary DHEA ELISA Kit	1-1202	Catalog#:1-1202 Format:96-well plate Assay Time:~ 4 hrs Sample Volume/Test:50 µL Sensitivity:5 pg/mL Assay Range:10.2 pg/mL - 1000 pg/mL Storage Requirements:2-8°C Optimum Collection Volume:125 μL* Collect With:SalivaBio Passive Drool Serum-Saliva Correlation:0.86
Salivary DHEA-S ELISA Kit	1-1252	Catalog#:1-1252 Format:96-well plate Assay Time:~ 2 hrs Sample Volume/Test:100 µL Sensitivity:43 pg/mL Assay Range:188.9 pg/mL- 15,300 pg/mL Storage Requirements:2-8°C Optimum Collection Volume:225 μL* Collect With:SalivaBio Passive Drool Serum-Saliva Correlation:NA
Salivary Estradiol ELISA Kit	1-3702	Catalog#:1-3702 Format:96-well plate Assay Time:~ 3 hrs Sample Volume/Test:100 µL Sensitivity:0.1 pg/mL Assay Range:1 pg/mL - 32 pg/mL Storage Requirements:2-8°C Optimum Collection Volume:225 μL* Collect With:SalivaBio Passive Drool Serum-Saliva Correlation:0.80
Salivary Estriol ELISA Kit	1-1802	Catalog#:1-1802 Format:96-well plate Assay Time:~ 3 hrs Sample Volume/Test:25 µL Sensitivity:16 pg/mL Assay Range:20 pg/mL - 4860 pg/mL Storage Requirements:2-8°C Optimum Collection Volume:175 μL* Collect With:SalivaBio Passive Drool Serum-Saliva Correlation:0.87
HS Salivary Estriol ELISA Kit	1-1802	Catalog#:1-1802 Format:96-well plate Assay Time:~ 24 hrs Sample Volume/Test:100 µL of X2 dilution Sensitivity:1 pg/mL Assay Range:5 pg/mL - 1215 pg/mL Storage Requirements:2-8°C Optimum Collection Volume:175 μL* Collect With:SalivaBio Passive Drool Serum-Saliva Correlation:0.87
Salivary Estrone ELISA Kit	1-3202	Catalog#:1-3202 Format:96-well plate Assay Time:~ 4 hrs Sample Volume/Test:100 µL Sensitivity:1 pg/mL Assay Range:3.1 pg/mL - 300 pg/mL Storage Requirements:2-8°C Optimum Collection Volume:255 μL* Collect With:SalivaBio Passive Drool Serum-Saliva Correlation:NA
Salivary Interleukin-1 Beta ELISA Kit	1-3902	Catalog#:1-3902 Format:96-well plate Assay Time:~ 4.5 hrs Sample Volume/Test:20 µL Sensitivity:<0.037 pg/mL Assay Range:3.13 pg/mL – 200 pg/mL Storage Requirements:2-8°C Optimum Collection Volume:50 μL* Collect With:SalivaBio Passive Drool SalivaBio Oral Swab (SOS) SalivaBio Children's Swab (SCS) SalivaBio Infant's Swab (SIS) Serum-Saliva Correlation:NA
Salivary Interleukin-6 ELISA Kit	1-3602	Catalog#: 1-3602 Format:96-well plate Assay Time:~ 4.5 hrs Sample Volume/Test:60 µL Sensitivity:0.07 pg/mL Assay Range:0 – 100 pg/mL Storage Requirements:2-8°C Optimum Collection Volume:135 μL Collect With:SalivaBio Passive Drool SalivaBio Oral Swab (SOS) SalivaBio Children's Swab (SCS) SalivaBio Infant's Swab (SIS) Serum-Saliva Correlation:NA
Salivary Melatonin ELISA Kit	1-3402	Catalog#:1-3402 Format:96-well plate Assay Time:~ 4 hrs Sample Volume/Test:100 µL Sensitivity:1.37 pg/mL Assay Range:0.78-50 pg/mL Storage Requirements:2-8°C Optimum Collection Volume:225 μL* Collect With:SalivaBio Passive Drool SalivaBio Oral Swab (SOS) SalivaBio Children's Swab (SCS) SalivaBio Infant's Swab (SIS) Serum-Saliva Correlation:0.81
Salivary Progesterone ELISA Kit	1-1502	Catalog#:1-1502 Format:96-well plate Assay Time:~ 2 hrs Sample Volume/Test:50 µL Sensitivity:5 pg/mL Assay Range:10 pg/mL - 2430 pg/mL Storage Requirements:2-8°C Optimum Collection Volume:125 μL* Collect With:SalivaBio Passive Drool Serum-Saliva Correlation:NA
Salivary Secretory IgA ELISA Kit	1-1602	Catalog#:1-1602 Format:96-well plate Assay Time:~ 4 hrs Sample Volume/Test:25 µL Sensitivity:2.5 µg/mL Assay Range:2.50 µg/mL – 600 µg/mL Storage Requirements:2-8°C Optimum Collection Volume:50 μL* Collect With:SalivaBio Passive Drool SalivaBio Oral Swab (SOS) SalivaBio Children's Swab (SCS) SalivaBio Infant's Swab (SIS) Serum-Saliva Correlation:
Salivary Testosterone ELISA Kit	1-2402	Catalog#:1-2402 Format:96-well plate Assay Time:~ 2 hrs Sample Volume/Test:25 µL Sensitivity:1 pg/mL Assay Range:6.1 pg/mL - 600 pg/mL Storage Requirements:2-8°C Optimum Collection Volume:75 μL* Collect With:SalivaBio Passive Drool SalivaBio Oral Swab (SOS) SalivaBio Children's Swab (SCS) SalivaBio Infant's Swab (SIS) Serum-Saliva Correlation:0.96
Salivary Transferrin/Blood Contamination ELISA Kit	1-1302	Catalog#:1-1302 Format:96-well plate Assay Time:~ 1.5 hrs Sample Volume/Test:25 µL Sensitivity:<0.007 ug/dL Assay Range:0.012-3.000 ug/dL Storage Requirements:2-8°C Optimum Collection Volume:75 μL* Sample Test Volume:20 µL Collect With:SalivaBio Passive Drool Assay Sensitivity:0.08 mg/dL Assay Range:0.08 mg/dL - 6.6 mg/dL Serum-Saliva Correlation:NA
Salivary Uric Acid Assay Kit	1-3802	Catalog#:1-3802 Format:96-well plate Assay Time:~ 30 mins Sample Volume/Test:10 µL Sensitivity:0.07 mg/dL LOD Assay Range:5 mg/dL (NIST certified) Storage Requirements:2-8°C Optimum Collection Volume:25 μL* Collect With:SalivaBio Passive Drool SalivaBio Oral Swab (SOS) SalivaBio Children's Swab (SCS) SalivaBio Infant's Swab (SIS) Serum-Saliva Correlation:0.84
Diagnostic Salivary Cortisol ELISA Kit (FDA, CE Mark)	1-3102	Catalog#:1-3102 Regulatory Status:510(k), CE Mark Format:96-well plate Assay Time:~ 2 hrs Sample Volume/Test:25 µL Sensitivity:<0.007 ug/dL Assay Range:0.012-3.000 ug/dL Storage Requirements:2-8°C Optimum Collection Volume:75 uL Collect With:SalivaBio Passive Drool SalivaBio Oral Swab (SOS) SalivaBio Children's Swab (SCS) SalivaBio Infant's Swab (SIS) Serum-Saliva Correlation:0.91
Diagnostic Salivary Cotinine ELISA Kit (FDA, CE Mark)	1-2112	Catalog#:1-2112 Regulatory Status:510(k) Exempt, CE Mark Format:96-well plate Assay Time:~ 2.5 hrs Sample Volume/Test:20 µL Sensitivity:0.15 ng/mL Assay Range:0.8 ng/mL - 200 ng/mL Storage Requirements:2-8°C Optimum Collection Volume:75 µL* Collect With:SalivaBio Passive Drool SalivaBio Oral Swab (SOS) SalivaBio Children's Swab (SCS) SalivaBio Infant's Swab (SIS) Serum-Saliva Correlation:NA
Diagnostic Salivary DHEA ELISA Kit (CE Mark)	1-2212	Catalog#:1-2212 Regulatory Status:CE Mark Format:96-well plate Assay Time:~ 4 hrs Sample Volume/Test:50 µL Sensitivity:5 pg/mL Assay Range:10.2 pg/mL - 1000 pg/mL Storage Requirements:2-8°C Optimum Collection Volume:125 μL* Collect With:SalivaBio Passive Drool Serum-Saliva Correlation:0.86
Diagnostic Salivary Estradiol ELISA Kit (FDA, CE Mark)	1-3702	Catalog#:1-3702 Regulatory Status:510(k) Exempt, CE Mark Format:96-well plate Assay Time:~ 3 hrs Sample Volume/Test:100 µL Sensitivity:0.1 pg/mL Assay Range:1 pg/mL - 32 pg/mL Storage Requirements:2-8°C Optimum Collection Volume:225 μL* Collect With:SalivaBio Passive Drool Serum-Saliva Correlation:0.80
Diagnostic Salivary Estriol ELISA Kit (CE Mark)	1-2812	Catalog#:1-2812 Regulatory Status:CE Mark Format:96-well plate Assay Time:~ 24 hrs Sample Volume/Test:100 µL of X2 dilution Sensitivity:1 pg/mL Assay Range:5 pg/mL - 1215 pg/mL Storage Requirements:2-8°C Optimum Collection Volume:175 μL* Collect With:SalivaBio Passive Drool Serum-Saliva Correlation:0.87
Diagnostic Salivary Progesterone ELISA Kit (FDA, CE Mark)	1-2502	Catalog#:1-2502 Regulatory Status:510(k) Exempt, CE Mark Format:96-well plate Assay Time:~ 2 hrs Sample Volume/Test:50 µL Sensitivity:5 pg/mL Assay Range:10 pg/mL - 2430 pg/mL Storage Requirements:2-8°C Optimum Collection Volume:125 μL* Collect With:SalivaBio Passive Drool Serum-Saliva Correlation:NA
Diagnostic Testosterone ELISA Kit (CE Mark)	1-2312	Catalog#:1-2312 Regulatory Status:CE Mark Format:96-well plate Assay Time:~2 hrs Sample Volume/Test:25 µL Sensitivity:1 pg/mL Assay Range:6.1 pg/mL - 600 pg/mL Storage Requirements:2-8°C Optimum Collection Volume:75 μL* Collect With:SalivaBio Passive Drool SalivaBio Oral Swab (SOS) SalivaBio Children's Swab (SCS) SalivaBio Infant's Swab (SIS) Serum-Saliva Correlation:0.96

< " data-original="http://gerbu.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Salimetrics"> Salimetrics

...

阅读详情

艾美捷科技代理Ligatrap品牌全系列产品

LigaTrap Technologies是一家位于北卡罗来纳州的创新型生物技术公司，提供独特的专利技术组合，专注于蛋白质纯化领域。LigaTrap精于抗体与病毒纯化，服务于抗体药物、病毒疫苗及基因治疗产业。

▍LigaTrap公司产品

● LigaGuard：最新推出的亲和吸附剂，是由多模态配体构成的专利复合体系，可在流穿模式（连续流）下选择性捕获宿主细胞蛋白（HCPs）与DNA。

● AAVidity™：一种新型亲和层析填料，用于血清型普适性纯化源自 HEK293 和 Sf9 细胞裂解液的腺相关病毒（AAV）。

● IgM Resin：专为纯化 IgM 抗体设计的亲和树脂，具有高纯度、高结合能力、温和的洗脱条件（pH 约 4.0），并可重复使用多达 100 次。

● Base Resin：专为从多克隆与单克隆来源中纯化高质量抗体而设计，该树脂推荐用于纯化：多种物种的 IgG（包括人、小鼠、兔等）；人源 IgA；鸡源 IgY。

● LigaTrap Buffers：包含Regeneration Buffer，Neutralization Buffer，Elution Buffer，Regeneration Buffer，Equilibration/Wash Buffer 2.0等。

▍LigaGuard

LigaGuard™树脂适用于两类核心产品的纯化：蛋白制品：单克隆抗体、生长因子；病毒制品：慢病毒、腺相关病毒（AAV）、病毒疫苗。该树脂的设计使目标生物产物无结合通过，实现高纯度与高回收率。其能清除传统纯化工艺难以去除的高残留性HCPs（HR-HCPs），显著提升终产物的纯度、稳定性、疗效与安全性。

品名	货号	规格
LigaTrap LigaGuard 1 ml Packed Column	LT-LG1-1x1mL	1mL
LigaTrap LigaGuard 5ml Packed Column	LT-LG1-1x5mL	5mL
LigaTrap LigaGuard Loose Resin - 5mL	LT-LG1	5 mL
LigaTrap LigaGuard Loose Resin - 10mL	LT-LG1-10mL	10 mL
LigaTrap LigaGuard Loose Resin - 25mL	LT-LG1-25mL	25 mL
LigaTrap LigaGuard Loose Resin - 50mL	LT-LG1-50mL	50 mL
LigaTrap LigaGuard Loose Resin - 100mL	LT-LG1-100mL	100 mL

▍AAVidity

AAVidity填料通过合成亲和配体功能化修饰，可捕获所有血清型的 AAV，提供卓越的结合载量与污染物（宿主细胞蛋白 HCPs 及宿主细胞DNA hcDNA清除能力。其温和洗脱条件在保障 AAV 转导活性的同时，实现高产物回收率。

品名	货号	规格
LigaTrap AAVidity Loose Resin – 1mL	LT-AAV-1mL	1mL
LigaTrap AAVidity Loose Resin – 5mL	LT-AAV-5mL	5mL
LigaTrap AAVidity Prepacked Column – 1mL	LT-AAV-1x1mL	1x1mL
LigaTrap AAVidity Prepacked Column – 5mL	LT-AAV-1x5mL	1x5mL

▍IgM Resin

IgM纯化树脂的核心优势包括：

● 全面捕获：同时结合IgM的重链与轻链亚型；

● 零风险：无免疫原性及配体脱落；

● 活性保全：温和洗脱条件保障抗体完整性；

● 经济耐用：消毒再生后可重复使用 ≥100 次；

● 该树脂能高效处理并纯化来自以下样本的单克隆 IgM：细胞培养上清，腹水，杂交瘤，其他重组 IgM 来源。

品名	货号	规格
IgM Microspin Column Kit w/ Buffers	LT-155KIT	KIT-10x0.1mL
IgM 1mL Prepacked Column Kit w/ Buffers	LT-155-1mL KIT	KIT-1x1mL
IgM 5mL Prepacked Column Kit w/ Buffers	LT-155-5mL KIT	KIT-1x5mL
IgM Loose Resin – 5mL	LT-155	5mL
IgM Loose Resin – 10mL	LT-155-10mL	10mL
IgM Loose Resin – 25mL	LT-155-25mL	25mL
IgM Loose Resin – 50mL	LT-155-50mL	50mL
IgM Loose Resin – 100mL	LT-155-100mL	100mL
IgM Microspin Columns without Buffers	LT-155-MSC	10x0.1mL
IgM Prepacked Column – 1mL	LT-155-1x1mL	1x1mL
IgM Prepacked Column – 5mL	LT-155-1x5mL	1x5mL
IgM Prepacked Columns – 3x1mL	LT-155-3x1mL	3x1mL

▍Base Resin

LigaTrap基础纯化树脂可实现高回收率与>95%的纯度，而传统Protein A和Protein G填料的回收率甚至低于检测限。通过优化工艺，该树脂的纯度可进一步提升至99%。

品名	货号	规格
Base Resin Microspin Column Kit w/ Buffers	LT-150KIT	KIT-10x0.1mL
Base Resin 1mL Prepacked Column Kit w/ Buffers	LT-150-1mL KIT	KIT-1x1mL
Base Resin 5mL Prepacked Column Kit w/ Buffers	LT-150-5mL KIT	KIT-1x5mL
Loose Base Resin – 5mL	LT-150	5mL
Loose Base Resin – 10mL	LT-150-10mL	10mL
Loose Base Resin – 25mL	LT-150-25mL	25mL
Loose Base Resin – 50mL	LT-150-50mL	50mL
Loose Base Resin – 100mL	LT-150-100mL	100mL
Base Resin Microspin Columns without Buffers	LT-150-MSC	10x0.1mL
Base Resin Prepacked Column – 1mL	LT-150-1x1mL	1x1mL
Base Resin Prepacked Column – 5mL	LT-150-1x5mL	1x5mL
Base Resin Prepacked Columns – 3x1mL	LT-150-3x1mL	3x1mL

▍Buffers

品名	货号	规格
LigaTrap Elution Buffer	BU-123-FP	125ml
LigaTrap Regeneration Buffer	BU-124-FP	50ml
LigaTrap Neutralization Buffer	BU-125-FP	15ml
LigaTrap Storage Buffer	BU-126-FP	50 ml
LigaTrap Sample Diluent 2.0	BU-131-FP	15 ml
LigaTrap Equilibration/Wash Buffer 2.0	BU-132-FP	250ml
LigaTrap IgM Elution Buffer pH 3.8	BU-133-FP	125 ml
LigaTrap Elution Buffer	BU-123-500-FP	500ml
LigaTrap Regeneration Buffer	BU-124-500-FP	500 ml
LigaTrap Neutralization Buffer	BU-125-250-FP	250 ml
LigaTrap Storage Buffer	BU-126-500-FP	500 ml
LigaTrap Sample Diluent 2.0	BU-131-250-FP	250 ml
LigaTrap Equilibration/Wash Buffer 2.0	BU-132-1-FP	1L
LigaTrap IgM Elution Buffer pH 3.8	BU-133-500-FP	500ml

" data-original="http://gerbu.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Ligatrap品牌全系列产品"> 艾美捷科技代理Ligatrap品牌全系列产品

...

阅读详情

Diarect有着20多年自身抗原研发经验的Liedvogel教授和Hanbruck博士联手创建。1993年Haubruck博士利用杆状病毒/Sf9昆虫细胞表达系统成功的研发出人重组抗原--TPO，6年后Diarect是第一家将人重组TPO引进体外诊断市场的公司。

Established in 1998, DIARECT AG is a privately owned biotech company with expertise in developing and establishing standardized large-scale productions of both recombinant and native proteins, including their worldwide distribution. Providing customers with products and services of consistent quality is one of the cornerstones of DIARECT’s business philosophy.

DIARECT is not only a leading manufacturer of autoimmune and infectious disease antigens, but also of recombinant allergens. In additon, DIARECT is the exclusive distributor of Surmodics in Europe. With Surmodics' protein stabilization reagents, blockers and BioFX substrates, DIARECT is able to provide most of the critical components for the development of diagnostic end products.

Diarect公司的主要产品包括：

Allergens

Autoimmune Disease Antigens

Infectious Disease Antigens

Antigen FAQ

Selected References

Protein Stabilizers / Blockers

Immunoassay Stabilizers

Protein and Conjugate Stabilizers

Microsphere and Microarray Stabilizers

StabilBlot™ Blockers

Protein Stabilizers / Blockers FAQ

Selected References

Immunoassay Substrates

更多详情请联系

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

< " data-original="http://gerbu.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Diarect"> Diarect

...

阅读详情

艾美捷科技特约代理Bethyl Laboratories全系列产品。

Bethyl Laboratories公司是世界著名的一抗和二抗生产商，成立于1972年，美国农业部(USDA)认证企业,符合GMP标准。致力于给研究者提供高品质抗体。主要生产抗体为细胞生物学类。公司为临床和科研提供高品质的抗体生产和服务，拥有世界上最丰富的细胞凋亡产品。如：凯氏半胱氨酸蛋白酶分析试剂盒和试剂，细胞凋亡检测试剂盒及试剂，与细胞凋亡相关的抗体，细胞增殖和细胞毒性检测试剂盒，生长因子，细胞因子和趋化因子，分子生物学试剂盒及试剂等研究产品。此外，该公司生产的各种动物免疫球蛋白的elisa试剂盒，规格一般为10x96T，性价比优越，颇受广大科研工作者的亲睐。

Bethyl Laboratories, Inc. has been dedicated to supporting scientific discovery through its qualified antibody products and custom polyclonal antibody services since its founding in 1972. With over 45 years of experience, Bethyl is also a leading provider of custom polyclonal antibody production services. Bethyl offers complete packages from initial peptide synthesis to affinity purification of custom polyclonal antibodies from an antigen-specific immunosorbent. Most recently, our capabilities have expanded and we now offer contract recombinant rabbit monoclonal antibody partnerships.

Bethyl Laboratories公司的主要产品包括：

Cell Lysate Preparation

Western Blot (WB)

Immunoprecipitation

Immunohistochemistry (IHC)

ELISA

Proximity Ligation Assay (PLA)

Flow Cytometry

Dilutions

Terms and Abbreviations

" data-original="http://gerbu.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技特约代理Bethyl Laboratories全系列产品"> 艾美捷科技特约代理Bethyl Laboratories全系列产品

...

阅读详情

PhosphoSolutions成立于2001年，由Drs. Michael D. Browning, John W. Haycock, and Andrew J. Czernik 等一同创立，已发展成为在神经科学领域的蛋白及抗体的领先供应商。

PhosphoSolutions was founded in 2001 by Drs. Michael D. Browning, John W. Haycock, and Andrew J. Czernik who all worked together in the laboratory of Dr. Paul Greengard, co-recipient of the 2000 Nobel Prize in Medicine for his work on the role of protein phosphorylation in signal transduction in the nervous system. This expertise has led us to focus primarily on proteins of interest in the neuroscience field.

PhosphoSolutions公司的主要产品包括：

Cardiovascular

Catecholamine Signaling

Cell Markers

Cytoskeletal and Nuclear Proteins

DNA Damage

Extracellular Matrix Proteins

GABA Receptors

Glutamate Receptors and Associated Signaling Proteins

Hormone Biosynthesis

Neurodegenerative Disease

Neurogenesis and Development

Neurotransmission

Oncoproteins

RNA Processing

Signal Transduction

Steroid Hormone Receptors

Synaptic Vesicle Proteins

Uncategorized

Visual System

更多详情请联系

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

" data-original="http://gerbu.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="PhosphoSolutions"> PhosphoSolutions

...

阅读详情

艾美捷科技代理Berry & Associates全系列修饰核苷酸等

美国 Berry & Associates 公司成立于1989年，提供近200种亚磷酰胺和核苷酸合成用固相交联单体，以及数百种核苷、核苷酸、糖类、荧光标记物、淬灭剂和杂环化合物。

Founded in 1989 with roots in the nucleoside field, Berry & Associates soon moved into the chemistry of nucleic acids, resulting in a current portfolio of nearly 200 phosphoramidites and solid phase-linked monomers for oligonucleotide synthesis as well as hundreds of nucleosides, nucleotides, carbohydrates, spacers, fluorescent markers, quenchers, and heterocycles - all proudly made at our facility just outside of Ann Arbor, Michigan. Although our company is small, the credentials of our highly trained staff of chemists include over 400 publications and 80 patents in synthetic organic and medicinal chemistry. High quality chemicals, timeliness, and personalized service are the hallmarks of Berry & Associates.

Berry & Associates的主要产品包括：

产品名称	产品编号	纯度	规格
2',3'-Dideoxyadenosine	PR 3495	≥95%	25 mg; 100 mg
2'-3'-Dideoxyguanosine	PR 3505	≥95%	25 mg; 100 mg
2',3'-Dideoxyinosine	PR 3727	≥97%	100 mg; 1 g
3'-Deoxythymidine	PY 7277	≥95%	50 mg; 100 mg
2',3'-Dideoxyuridine	PY 7278	≥97%	100 mg; 500 mg
2',3'-Didehydro-2',3'-dideoxyuridine	PY 7279	≥97%	25 mg; 100 mg
2',3'-Dideoxycytidine	PY 7325	≥95%	50 mg; 100 mg
2-Aminoadenosine (2,6-Diaminopurine riboside)	PR 3030	≥97%	2 g; 10 g
2-Amino-2'-deoxyadenosine	PR 3060	≥97%	1 g; 5 g
2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-deoxyadenosine	PR 3080	≥95%	100 mg; 1 g
2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine	PR 3090	≥97%	250 mg; 1 g
2-Amino-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine	PR 3110	≥95%	250 mg; 1 g
2-Amino-N2-isobutyryl-2'-deoxyadenosine	PR 3130	≥95%	100 mg; 1 g
2-Amino-N2-O-methyladenosine	PR 3150	≥97%	1 g; 10 g
2-(Dimethylaminomethylidene)amino-6-methoxylamino-9-(β-D-2-deoxyribofuranosyl)purine	PR 3670	≥95%	100 mg; 1 g
2-Amino-9-(β-D-2'-deoxyribfuranosyl)purine	PR 3070	≥97%	25 mg; 100 mg
2-Amino-9-(2-O-methyl-β-D-ribofuranosyl)purine	PR 3160	≥97%	100 mg; 250 mg
2-Amino-9-(β-D-ribofuranosy)purine Hemihydrate	PR 3180	≥97%	25 mg; 100 mg
2-(Dimethylaminomethylidene)amino-9-(β-D-2-deoxyribofuranosyl)purine	PR 3680	≥97%	100 mg; 1 g
6-N-Acyl-6-N-methyl-2'-deoxyadenosine	PR 3006	≥95%	25 mg; 100 mg
8-Amino-2'-deoxyadenosine	PR 3115	≥97%	10 mg; 100 mg
N6-(6-Aminohexyl)-2'-deoxyadenosine	PR 3120	≥90%	100 mg; 1 g
8-Azido-2'-deoxyadenosine	PR 3125	≥97%	10 mg; 100 mg
N6-Benzoyl-8-benzyloxy-2'-deoxyadenosine	PR 3230	≥95%	50 mg; 250 mg
N6-Benzoyl-5'-O-(dimethoxytrityl)-8-oxo-2'-deoxyadenosine	PR 3260	≥95%	100 mg; 1 g
N6-Benzoyl-8-oxo-2'-deoxyadenosine	PR 3270	≥97%	100 mg; 1 g
8-Benzyloxy-2'-deoxyadenosine	PR 3280	≥97%	100 mg; 1 g
8-Bromo-2'-deoxyadenosine	PR 3290	≥90%	2 g; 10 g
8-Bromo-N6-(dimethylaminomethylidene)-2'-deoxyadenosine	PR 3320	≥95%	100 mg; 1 g
8-Bromo-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-2'-deoxyadenosine	PR 3340	≥97%	0g (discontinued);
2'-Deoxyadenosine Monohydrate	PR 3445	≥97%	25 g; 100 g
2',3'-Dideoxyadenosine	PR 3495	≥95%	25 mg; 100 mg
2-Fluoro-2'-deoxyadenosine	PR 3496	≥97%	25 mg; 1 g
8-Oxo-2'-deoxyadenosine	PR 3705	≥95%	25 mg; 250 mg
N6-Methyl-2'-deoxyadenosine	PR 3740	≥97%	100 mg; 1 g
4-Chloro-1-(2-deoxy-β-D-ribofuranosyl)-7-methyl-1H-imidazo[4,5-c]pyridine	PRA 10012	≥95%	10 mg; 50 mg
3-Deaza-3-methyl-2'-deoxyadenosine	PRA 10013	≥97%	10 mg; 25 mg
5'-O-Dimethoxytrityl-N6-(N,N-dimethylaminomethylene)-8-aza-7-deaza-2'-deoxyadenosine	PRA 10019	≥97%	500 mg; 1 g
7-(3-Nitrophenyl)-7-deaza-2'-deoxyadenosine	PRA 10032	≥95%	10 mg; 50 mg
5-Iodo-2'-deoxytubercidin	PRA 10036	≥95%	10 mg; 50 mg
8-Allyloxy-2'-deoxyguanosine	PR 3010	≥90%	0Discontinued;
8-Allyloxy-N2-(dimethylaminomethylidene)-2'-deoxyguanosine	PR 3015	≥90%	1 g; 10 g
8-Allyloxy-N2-isobutyryl-2'-deoxyguanosine	PR 3020	≥90%	1 g; 10 g
5'-Azido-5'-deoxyguanosine	PR 3225	≥90%	5 mg; 10 mg
8-Benzyloxy-N2-isobutyryl-2'-deoxyguanosine	PR 3285	≥90%	1 g; 10 g
8-Bromo-2'-deoxyguanosine	PR 3300	≥90%	1 g; 5 g
8-Bromo-5'-O-(dimethyoxytrityl)-N2-(dimethyl-aminomethylidene)-2'-deoxyguanosine	PR 3310	≥97%	500 mg; 1 g
8-Bromo-N2-(dimethylaminomethylidene)-2'-deoxyguanosine	PR 3330	≥90%	250 mg; 1 g
5'-O-Dimethoxytrityl-N2-(dimethylaminomethylidene)-8-ethenyl-2'-deoxyguanosine	PR 3335	≥95%	100 mg; 1 g
2'-Deoxyguanosine monohydrate	PR 3452	≥97%	10 g; 100 g
α-2'-Deoxyguanosine	PR 3455	≥97%	10 mg; 100 mg
2'-Deoxyisoguanosine	PR 3465	≥97%	10 mg; 100 mg
5'-O-(Dimethoxytrityl)-N2-ethyl-2'-deoxyguanosine	PR 3600	≥97%	100 mg; 1 g
3',5'-Di-O-acetyl-2'-deoxyguanosine	PR 3605	≥97%	500 mg; 1 g
5'-O-(Dimethoxytrityl)-8-Oxo-N2-isobutyryl-2'-deoxyguanosine	PR 3610	≥97%	100 mg; 1 g
5'-O-(Dimethoxytrityl)-N2-methyl-2'-deoxy-guanosine	PR 3630	≥97%	100 mg; 1 g
N2-Ethyl-2'-deoxyguanosine	PR 3700	≥95%	25 mg; 100 mg
5'-O-Dimethoxytrityl-N2-(trifluoroacetamido)hexyl-2'-deoxyguanosine	PR 3701	≥95%	25 mg; 100 mg
8-Oxo-2'-deoxyguanosine	PR 3710	≥97%	25 mg; 250 mg
8-Oxo-N2-isobutyryl-2'-deoxyguanosine	PR 3720	≥90%	100 mg; 1 g
N2-Isobutyl-2'-deoxyguanosine	PR 3745	≥97%	10 mg; 100 mg
N1-Methyl-2'-deoxyguanosine	PR 3748	≥97%	25 mg; 1 g
N2-Methyl-2'-deoxyguanosine	PR 3750	≥97%	25 mg; 100 mg
O6-Methyl-2'-deoxyguanosine	PR 3755	≥90%	5 mg; 25 mg
6-Thio-2'-deoxyguanosine	PR 3845	≥97%	10 mg; 100 mg
7-Methyl-7-deaza-2'deoxyguanosine	PRA 10042	≥97%	10 mg; 50 mg
2'-Deoxypseudoguanosine	PRA 10103	≥97%	10 mg; 50 mg
2'-Deoxypseudoisoguanosine	PRA 10104	≥97%	10 mg; 100 mg
8-Aza-7-deaza-2'-deoxyguanosine	PRA 10170	≥95%	10 mg; 100 mg
6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one	PRA 10175	≥95%	10 mg; 100 mg
2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine	PR 3090	≥97%	250 mg; 1 g
2-Amino-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine	PR 3110	≥95%	250 mg; 1 g
2-Amino-N2-O-methyladenosine	PR 3150	≥97%	1 g; 10 g
2',3'-Di-O-methyladenosine	PR 3540	≥97%	100 mg; 1 g
5'-O-(Dimethoxytrityl)-2'-O-methylinosine	PR 3640	≥97%	1 g;
N6-Methyl-2'-O-Methyladenosine	PR 3733	≥97%	50 mg; 100 mg
2'-O-Methyladenosine	PR 3734	≥97%	1 g;
2'-O-Methylguanosine	PR 3760	≥97%	1 g; 10 g
2'-O-Methylinosine	PR 3770	≥97%	500 mg; 1 g
N4-Acetyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine	PY 7010	≥95%	0 g DISCONTINUED;
N4-Acetyl-5'-methyl-2'-O-methylcytidine	PY 7020	≥97%	0 g DISCONTINUED;
N4-Benzoyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine	PY 7100	≥95%	100 mg; 1 g
N4-Benzoyl-2'-O-methylcytidine	PY 7110	≥97%	500 mg; 1 g
3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine	PY 7290	≥95%	500 mg; 1 g
3',5'-Di-O-acetyl-5-fluoro-2'-O-methyluridine	PY 7300	≥97%	50 mg; 250 mg
3',5'-Di-O-benzoyl-5-fluoro-2'-O-methyluridine	PY 7320	≥97%	500 mg; 1 g
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-iodo-2'-O-methylcytidine	PY 7350	≥97%	0 DISCONTINUED;
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine	PY 7360	≥97%	0 DISCONTINUED;
N4-(Diisobutylaminomethylidene)-5-iodo-2'-O-methylcytidine	PY 7370	≥97%	0 DISCONTINUED;
5'-O-(Dimethoxytrityl)-5-fluoro-2'-O-methyluridine	PY 7420	≥95%	100 mg; 500 mg
5'-O-(Dimethoxytrityl)-5-iodo-2'-O-methyluridine	PY 7460	≥97%	50 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-methyl-2'-O-methyluridine	PY 7470	≥97%	100 mg; 1 g
5'-O-(Dimethoxytrityl)-2'-O-methyluridine	PY 7480	≥97%	500 mg; 1 g
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine	PY 7500	≥95%	25 mg; 100 mg
5-Fluoro-2'-O-methyluridine	PY 7570	≥97%	50 mg; 100 mg
5-Fluoro-2'-O-methyl-4-thiouridine	PY 7575	≥97%	10 mg; 100 mg
5-Fluoro-2'-O-methyl-4-(methylithio)uridine	PY 7577	≥97%	10 mg; 100 mg
5-Iodo-2'-O-methylcytidine	PY 7620	≥90%	20 mg; 100 mg
5-Iodo-2'-O-methyluridine	PY 7630	≥97%	100 mg; 1 g
2'-O-Methylcytidine	PY 7636	≥97%	1 g; 5 g
5-Methyl-2'-O-methylcytidine	PY 7640	≥97%	100 mg; 500 mg
5-Methyl-2'-O-methyluridine	PY 7650	≥97%	100 mg; 1 g
5-(1-Propynyl)-2'-O-methylcytidine	PY 7660	≥95%	10 mg; 50 mg
5-(1-Propynyl)-2'-O-methyluridine	PY 7670	≥97%	10 mg; 25 mg
2'-O-Methyluridine	PY 7690	≥97%	5 g;
5'-O-Acetyl-3'-azido-N2-palmitoyl-2',3'-dideoxy-guanosine	PR 3000	≥97%	25 mg; 250 mg
3'-Azido-N6-benzoyl-2',3'-dideoxyadenosine	PR 3200	≥90%	50 mg; 250 mg
3'-Azido-2',3'-dideoxyadenosine	PR 3210	≥97%	10 mg; 25 mg
3'-Azido-2',3'-dideoxyguanosine	PR 3220	≥97%	10 mg; 25 mg
3'-Azido-3'-deoxythymidine (AZT)	PY 7065	≥97%	500 mg; 1 g
3'-Azido-3'-deoxy-5'-O-methylthymidine	PY 7075	≥97%	0 g DISCONTINUED;
3'-Azido-2',3'-dideoxy-5-bromouridine	PY 7286	≥97%	10 mg; 50 mg
N6-Benzoyl-3'-deoxyadenosine	PR 3240	≥97%	100 mg; 1 g
N6-Benzoyl-5'-O-(dimethoxytrityl)-3'-deoxyadenosine	PR 3250	≥97%	100 mg; 1 g
3'-Deoxyadenosine	PR 3430	≥97%	10 mg; 100 mg
3'-Deoxyguanosine	PR 3460	≥97%	10 mg; 100 mg
5'-O-(Dimethoxytrityl)-N2-(dimethylaminomethylidene)-3'-deoxyguanosine	PR 3590	≥97%	100 mg; 1 g
N2-(Dimethylaminomethylidene)-3'-deoxyguanosine	PR 3690	≥97%	20 mg; 100 mg
2'-O-Acetyl-5'-O-benzoyl-5-methyl-3'-deoxyuridine	PY 7000	≥97%	500 mg; 1 g
N4-Benzoyl-3'-deoxycytidine	PY 7080	≥97%	20 mg; 100 mg
3'-Deoxycytidine	PY 7220	≥97%	20 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-methyl-3'-deoxyuridine	PY 7240	≥95%	25 mg; 100 mg
5-Methyl-3'-deoxyuridine	PY 7260	≥95%	20 mg; 50 mg
5'-O-(Dimethoxytrityl)-5,6-dihydro-2'-deoxyuridine	PY 7230	≥97%	100 mg;
5,6-Dihydro-2'-deoxyuridine	PY 7330	≥97%	100 mg;
(5S)-5,6-Dihydrothymidine	PY 7340	≥97%	20 mg; 100 mg
(5S)-5'-O-(Dimethoxytrityl)-5,6-dihydrothymidine	PY 7390	≥97%	100 mg;
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine	PY 7360	≥97%	0 DISCONTINUED;
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-deoxycytidine	PY 7400	≥97%	100 mg; 500 mg
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-deoxyuridine	PY 7490	≥95%	50 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine	PY 7500	≥95%	25 mg; 100 mg
5-(1-Propynyl)-2'-O-methylcytidine	PY 7660	≥95%	10 mg; 50 mg
5-(1-Propynyl)-2'-O-methyluridine	PY 7670	≥97%	10 mg; 25 mg
5-(1-Propynyl)-2'-deoxycytidine	PY 7700	≥90%	5 mg; 10 mg
5-(1-Propynyl)-2'-deoxyuridine	PY 7710	≥97%	100 mg; 1 g
2-Amino-6-chloro-9-(β-D-2-deoxyribofuranosyl)purine	PR 3040	≥97%	1 g;
2-Amino-6-chloro-9-(3,5-di-(p-toluoyl)-β-D-2-deoxyribofuranosyl)purine	PR 3045	≥95%	1 g;
2-Amino-6-chloro-9-(β-D-ribofuranosyl)purine	PR 3050	≥95%	5 g; 25 g
6-Chloro-9-(β-D-2-deoxyribofuranosyl)purine	PR 3370	≥97%	100 mg; 1 g
6-Chloro-9-(3,5-O-di-(p-toluoyl)-β-D-2-deoxyribofuranosyl)purine	PR 3380	≥90%	100 mg; 1 g
6-Chloro-9-(5-O-dimethoxytrityl-β-D-2-deoxyribofuranosyl)purine	PR 3390	≥97%	0 g;
6-Chloro-9-(β-D-ribofuranosyl)purine	PR 3400	≥97%	5 g; 10 g
Adenosine	PR 3005	≥97%	100 g; 1 kg
8-Methyladenosine	PR 3007	≥95%	25 mg; 100 mg
Vidarabine	PR 3008	≥97%	1 g; 5 g
2-Aminoadenosine (2,6-Diaminopurine riboside)	PR 3030	≥97%	2 g; 10 g
N1-Methyladenosine hydroiodide	PR 3032	≥95%	100 mg; 1 g
2-Methyladenosine	PR 3035	≥97%	10 mg; 25 mg
5'-Chloro-5'-deoxyadenosine	PR 3360	≥97%	100 mg; 1 g
N6-Methyladenosine	PR 3732	≥97%	100 mg; 1 g
N6-Methyl-2'-O-Methyladenosine	PR 3733	≥97%	50 mg; 100 mg
3-Deaza-3-methyl-2'-deoxyadenosine	PRA 10013	≥97%	10 mg; 25 mg
7-Deazaadenosine (tubercidin)	PRA 10035	≥97%	10 mg; 100 mg
5-Iodo-2'-deoxytubercidin	PRA 10036	≥95%	10 mg; 50 mg
2-Amino-4-chloro-7-(β-D-2-deoxyribofuranosyl)pyrrolo[2,3-d]pyrimidine	PRA 10000	≥97%	100 mg; 1 g
2-Amino-4-methoxy-7-(β-D-2-deoxyribofuranosyl)pyrrolo[2,3-d]pyrimidine	PRA 10005	≥97%	500 mg; 1 g
4-Chloro-1-(β-D-2-deoxyribofuranosyl)imidazo[4,5-C]pyridine	PRA 10006	≥90%	25 mg; 100 mg
8-Azaadenosine	PRA 10007	≥97%	20 mg;
8-Aza-7-deaza-2'-deoxyadenosine (4-Amino-1-(2-deoxyribofuranosyl)pyrazolo[3,4-d]-pyrimidine)	PRA 10008	≥95%	10 mg; 100 mg
4-Chloro-1-(3,5-di-O-toluoyl-2-deoxy-β-D-ribofuranosyl)pyrazolo[3,4-d]pyrimidine	PRA 10009	≥95%	100 mg; 1 g
N6-Benzoyl-7-deaza-2'-deoxyadenosine	PRA 10010	≥97%	100 mg; 1 g
Allopurinol riboside	PRA 10011	≥97%	25 mg; 1 g
5'-O-Dimethoxytrityl-N6-(N,N-dimethylaminomethylene)-8-aza-7-deaza-2'-deoxyadenosine	PRA 10019	≥97%	500 mg; 1 g
N6-Benzoyl-5'-O-(dimethoxytrityl)-7-deaza-2'-deoxyadenosine	PRA 10020	≥97%	100 mg; 1 g
3-Deaza-2'-deoxyadenosine	PRA 10025	≥97%	25 mg; 100 mg
7-Deaza-2'-deoxyadenosine	PRA 10030	≥97%	100 mg; 1 g
7-Deazaadenosine (tubercidin)	PRA 10035	≥97%	10 mg; 100 mg
5-Iodo-2'-deoxytubercidin	PRA 10036	≥95%	10 mg; 50 mg
7-Deaza-2'-deoxyguanosine	PRA 10040	≥97%	100 mg; 1 g
7-Deazaguanosine	PRA 10045	≥97%	10 mg; 100 mg
7-Deaza-2'-deoxyxanthosine	PRA 10050	≥97%	50 mg; 100 mg
5'-O-(Dimethoxytrityl)-7-deaza-2'-deoxyxanthosine	PRA 10055	≥97%	100 mg; 1 g
1-(β-D-2-Deoxyribofuranosyl)-5-nitroindole	PRA 10060	≥97%	100 mg; 1 g
1-(β-D-2-Deoxyribofuranosyl)-4-methylindole	PRA 10070	≥97%	0 g;
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-4-methylindole	PRA 10080	≥97%	0 g;
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-5-nitroindole	PRA 10090	≥97%	100 mg; 1 g
5-Iodotubercidin	PRA 10095	≥90%	5 mg; 25 mg
5'-O-(Dimethoxytrityl)-N2-(dimethylaminomethylidene)-7-deaza-2'-deoxyguanosine	PRA 10100	≥97%	100 mg; 1 g
N2-(Dimethylaminomethylidene)-7-deaza-2'-deoxyguanosine	PRA 10110	≥97%	100 mg; 1 g
Sangivamycin	PRA 10140	≥97%	10 mg; 25 mg
Toyocamycin	PRA 10150	≥97%	10 mg; 100 mg
Triciribine	PRA 10160	≥97%	10 mg;
Tricyclic Nucleoside Phosphate	PRA 10162	≥95%	10 mg;
8-Aza-7-deaza-2'-deoxyguanosine	PRA 10170	≥95%	10 mg; 100 mg
6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one	PRA 10175	≥95%	10 mg; 100 mg
Formycin A	PYA 11001	≥97%	10 mg;
Formycin B	PYA 11002	≥97%	10 mg;
dNaM	FC 8110	≥97%	25 mg; 100 mg
9-Deaza-2'-deoxyguanosine	PRA 10120	≥97%	10 mg; 100 mg
9-Deazaguanosine	PRA 10130	≥97%	10 mg; 100 mg
2-Chloro-6-(β-D-2-deoxyribofuranosyl)-3,5-diaminopyrazine	PYA 11000	≥97%	10 mg; 25 mg
Formycin A	PYA 11001	≥97%	10 mg;
Formycin B	PYA 11002	≥97%	10 mg;
Pyrazofurin	PYA 11004	≥97%	10 mg;
2'-Deoxypseudoisocytidine	PYA 11005	≥97%	10 mg; 100 mg
2'-Deoxypseudouridine	PYA 11010	Purity: ≥97%	25 mg;
5'-O-(Dimethoxytrityl)-N-(dimethylamino) methylidene-2'-deoxypseudoisocytidine	PYA 11035	Purity: ≥97%	50 mg; 100 mg
1,3-Dimethyl-2'-deoxypseudouridine	PYA 11040	≥97%	10 mg; 100 mg
1,3-Dimethylpseudouridine	PYA 11050	≥97%	10 mg; 50 mg
N1-Methylpseudouridine	PYA 11052	≥95%	10 mg; 50 mg
N3-Methylpseudouridine	PYA 11054	≥97%	10 mg; 25 mg
Showdomycin	PYA 11056	≥97%	10 mg;
Pseudoisocytidine hydrochloride	PYA 11060	≥97%	10 mg; 100 mg
Pseudothymidine	PYA 11070	≥97%	10 mg; 100 mg
Pseudouridine	PYA 11080	≥97%	10 mg; 50 mg
3'-O-(t-Butyldimethylsilyl)-5'-oxo-2'-deoxy-8,5'-cycloadenosine	PR 3350	≥97%	10 mg;
(5'S)-8,5'-Cycloadenosine	PR 3410	≥97%	10 mg; 100 mg
(5'S)-2'-Deoxy-8,5'-cycloadenosine	PR 3420	≥97%	10 mg;
5'-Deoxy-8,5'-cycloadenosine	PR 3440	≥97%	10 mg; 100 mg
2',5'-Dideoxy-8,5'-cycloadenosine	PR 3500	≥97%	10 mg;
2',3'-O-Isopropylidene-5'-oxo-8,5'-cycloadenosine	PR 3730	≥97%	10 mg; 100 mg
5'-Oxo-8,5'-cycloadenosine	PR 3800	≥97%	10 mg; 100 mg
5'-Oxo-2'-deoxy-8,5'-cycloadenosine	PR 3810	≥97%	10 mg;
N4-Acetyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine	PY 7010	≥95%	0 g DISCONTINUED;
N4-Acetyl-5'-methyl-2'-O-methylcytidine	PY 7020	≥97%	0 g DISCONTINUED;
N4-Benzoyl-5-(furan-2-yl)-2'-deoxycytidine	PY 7054	≥97%	25 mg; 100 mg
N4-Benzoyl-3'-deoxycytidine	PY 7080	≥97%	20 mg; 100 mg
N4-Benzoyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine	PY 7100	≥95%	100 mg; 1 g
N4-Benzoyl-2'-O-methylcytidine	PY 7110	≥97%	500 mg; 1 g
5-Bromo-2'-deoxycytidine	PY 7115	≥97%	1 g; 10 g
Cytidine	PY 7215	≥97%	50 g; 500 g
2'-Deoxycytidine	PY 7216	≥97%	10 g; 50 g
2'-Deoxycytidine Hydrochloride	PY 7217	≥97%	5 g; 50 g
5'-Azido-2',5'-dideoxycytidine	PY 7219	≥97%	25 mg; 100 mg
3'-Deoxycytidine	PY 7220	≥97%	20 mg; 100 mg
N4-Ethyl-2'-deoxycytidine	PY 7245	≥97%	100 mg; 250 mg
5-Methyl-2'-deoxyisocytidine	PY 7255	≥95%	500 mg; 1 g
6-(β-D-2-Deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-c][1,2]oxazin-7-one	PY 7270	≥97%	20 mg; 50 mg
2',3'-Dideoxycytidine	PY 7325	≥95%	50 mg; 100 mg
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-iodo-2'-O-methylcytidine	PY 7350	≥97%	0 DISCONTINUED;
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine	PY 7360	≥97%	0 DISCONTINUED;
N4-(Diisobutylaminomethylidene)-5-iodo-2'-O-methylcytidine	PY 7370	≥97%	0 DISCONTINUED;
6-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-c][1,2]oxazin-7-one	PY 7380	≥97%	50 mg;
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-deoxycytidine	PY 7400	≥97%	100 mg; 500 mg
5-O-(Dimethoxytrityl)-N4-dimethylaminomethylidene-5-iodo-2'-deoxycytidine	PY 7410	≥97%	100 mg;
6-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido[4,5-c][1,2]oxazin-7-one	PY 7540	≥95%	250 mg; 500 mg
Cytidin-5-yl-methanesulfonate sodium salt hydrate	PY 7586	≥95%	50 mg; 100 mg
5-[(2-Cyanoethoxy)methyl]-2'-deoxycytidine	PY 7587	≥97%	10 mg; 50 mg
5-Hydroxymethyl-2'-deoxycytidine	PY 7588	≥97%	50 mg; 100 mg
5-Formyl-2'-deoxycytidine	PY 7589	≥97%	5 mg; 10 mg
5-Carboethoxy-2'-deoxycytidine	PY 7592	≥95%	25 mg; 100 mg
2'-Deoxycytidine-5-carboxylic acid, sodium salt	PY 7593	≥95%	25 mg; 100 mg
5-Hydroxy-2'-deoxycytidine	PY 7595	≥95%	25 mg; 250 mg
5-Hydroxymethylcytidine	PY 7596	≥97%	50 mg; 100 mg
Cytidine-5-carboxylic acid, sodium salt	PY 7598	≥97%	10 mg; 50 mg
5-Formylcytidine	PY 7599	≥97%	5 mg; 10 mg
5-Iodo-2'-deoxycytidine	PY 7607	≥97%	2 g; 10 g
5-Iodocytidine	PY 7609	≥97%	5 g;
5-Iodo-2'-O-methylcytidine	PY 7620	≥90%	20 mg; 100 mg
5-Methyl-2'-deoxycytidine Hydrochloride	PY 7635	≥97%	0.25 g; 1 g
2'-O-Methylcytidine	PY 7636	≥97%	1 g; 5 g
5-Methylcytidine	PY 7637	≥97%	1 g; 5 g
N4-Methylcytidine	PY 7638	≥97%	25 mg; 100 mg
5-Methyl-2'-O-methylcytidine	PY 7640	≥97%	100 mg; 500 mg
6-Methylcytidine	PY 7641	≥97%	10 mg; 25 mg
5-(1-Propynyl)-2'-O-methylcytidine	PY 7660	≥95%	10 mg; 50 mg
5-(1-Propynyl)-2'-deoxycytidine	PY 7700	≥90%	5 mg; 10 mg
2-Thiocytidine	PY 7721	≥97%	10 mg; 100 mg
2-Thio-2'-deoxycytidine	PY 7723	≥95%	10 mg; 100 mg
3'-Deoxy-3',4'-didehydrocytidine	PY 7790	≥95%	10 mg; 25 mg
Pyrrolo-dC	PYA 11090	≥95%	10 mg; 100 mg
6-Methyl-3-(β-D-2-ribofuranosyl)pyrrolo[2,3-d]pyrimidin-2-one	PYA 11092	≥97%	10 mg; 100 mg
3-(5'-O-Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-6-methylpyrrolo[2,3-d]pyrimidin-2-one	PYA 11095	≥95%	100 mg; 1 g
3-(2'-Deoxy-β-D-2-ribofuranosyl)pyrido[2,3-d]pyrimidine-2,7(8H)-dione	PYA 11100	≥95%	10 mg; 100 mg
3,N4-Etheno-2'-deoxycytidine	PYA 11130	≥97%	100 mg; 500 mg
N6-Benzoyl-8-oxo-2'-deoxyadenosine	PR 3270	≥97%	100 mg; 1 g
(5'S)-8,5'-Cycloadenosine	PR 3410	≥97%	10 mg; 100 mg
(5'S)-2'-Deoxy-8,5'-cycloadenosine	PR 3420	≥97%	10 mg;
5'-O-(Dimethoxytrityl)-8-Oxo-N2-isobutyryl-2'-deoxyguanosine	PR 3610	≥97%	100 mg; 1 g
8-Oxo-2'-deoxyadenosine	PR 3705	≥95%	25 mg; 250 mg
8-Oxo-2'-deoxyguanosine	PR 3710	≥97%	25 mg; 250 mg
8-Oxo-N2-isobutyryl-2'-deoxyguanosine	PR 3720	≥90%	100 mg; 1 g
8-Hydroxyguanosine	PR 3795	≥97%	10 mg; 100 mg
8-Aza-7-deaza-2'-deoxyguanosine	PRA 10170	≥95%	10 mg; 100 mg
6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one	PRA 10175	≥95%	10 mg; 100 mg
5-Aza-2'-deoxycytidine	PY 7105	≥95%	25 mg; 100 mg
5,6-Dihydro-5-aza-2'-deoxycytidine	PY 7106	≥97%	25 mg; 100 mg
5,6-Dihydro-2'-deoxyuridine	PY 7330	≥97%	100 mg;
(5S)-5,6-Dihydrothymidine	PY 7340	≥97%	20 mg; 100 mg
5-Hydroxy-2'-deoxycytidine	PY 7595	≥95%	25 mg; 250 mg
5-Hydroxy-2'-deoxyuridine	PY 7597	≥95%	25 mg; 250 mg
5-(2-Hydroxyethyl)-2'-deoxyuridine	PY 7600	≥95%	25 mg; 50 mg
5-Hydroxymethyl-2'-deoxyuridine	PY 7605	≥95%	25 mg; 250 mg
6-Methylcytidine	PY 7641	≥97%	10 mg; 25 mg
Nap-dU	PY 7735	≥97%	10 mg; 25 mg
NPOM-Caged deoxythymidine	PY 7795	≥97%	25 mg; 100 mg
3,N4-Etheno-2'-deoxycytidine	PYA 11130	≥97%	100 mg; 500 mg
Pyrrolo-dC	PYA 11090	≥95%	10 mg; 100 mg
6-Methyl-3-(β-D-2-ribofuranosyl)pyrrolo[2,3-d]pyrimidin-2-one	PYA 11092	≥97%	10 mg; 100 mg
3-(5'-O-Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-6-methylpyrrolo[2,3-d]pyrimidin-2-one	PYA 11095	≥95%	100 mg; 1 g
3-(2'-Deoxy-β-D-2-ribofuranosyl)pyrido[2,3-d]pyrimidine-2,7(8H)-dione	PYA 11100	≥95%	10 mg; 100 mg
8-18O-Hydroxyguanosine	IOPR 3795	≥95%	2 mg; 5 mg
2'-Deoxyisoguanosine	PR 3465	≥97%	10 mg; 100 mg
5'-O-Dimethoxytrityl-N2-(trifluoroacetamido)hexyl-2'-deoxyguanosine	PR 3701	≥95%	25 mg; 100 mg
N2-Dimethylguanosine	PR 3702	≥97%	10 mg; 100 mg
Guanosine	PR 3703	≥97%	100 g; 500 g
Isoguanosine	PR 3735	≥97%	10 mg; 50 mg
O6-Methylguanosine	PR 3757	≥97%	25 mg; 100 mg
2'-O-Methylguanosine	PR 3760	≥97%	1 g; 10 g
7-Methyl-6-thioguanosine	PR 3790	≥75%	25 mg; 100 mg
8-Bromoguanosine	PR 3796	≥97%	0 g;
8-Benzyloxyguanosine	PR 3797	≥95%	100 mg; 1 g
7-Methyl-7-deaza-2'deoxyguanosine	PRA 10042	≥97%	10 mg; 50 mg
7-Deazaguanosine	PRA 10045	≥97%	10 mg; 100 mg
5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione	PRA 10047	≥97%	10 mg; 100 mg
2'-Deoxypseudoguanosine	PRA 10103	≥97%	10 mg; 50 mg
2'-Deoxypseudoisoguanosine	PRA 10104	≥97%	10 mg; 100 mg
1-(β-D-2-Deoxyribofuranosyl)-5-nitroindole	PRA 10060	≥97%	100 mg; 1 g
1-(β-D-2-Deoxyribofuranosyl)-4-methylindole	PRA 10070	≥97%	0 g;
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-4-methylindole	PRA 10080	≥97%	0 g;
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-5-nitroindole	PRA 10090	≥97%	100 mg; 1 g
2'-Deoxy-4-desmethylwyosine	PR 3450	≥95%	100 mg; 500 mg
2'-Deoxyinosine	PR 3463	≥97%	10 g; 100 g
5'-Azido-2',5'-dideoxyinosine	PR 3464	≥97%	5 mg; 25 mg
3',5'-Di-O-acetyl-2'-deoxyinosine	PR 3480	≥97%	1 g;
3',5'-Di-O-acetyl-O6-phenyl-2'-deoxyinosine	PR 3490	≥90%	1 g;
5'-O-(Dimethoxytrityl)-2'-O-methylinosine	PR 3640	≥97%	1 g;
5'-O-(Dimethoxytrityl)-O6-phenyl-2'-deoxyinosine	PR 3660	≥97%	100 mg; 1 g
Inosine	PR 3725	≥97%	100 g; 500 g
2',3'-Dideoxyinosine	PR 3727	≥97%	100 mg; 1 g
2'-O-Methylinosine	PR 3770	≥97%	500 mg; 1 g
7-Methylinosine	PR 3780	≥95%	100 mg; 250 mg
O6-Phenyl-2'-deoxyinosine	PR 3840	≥97%	100 mg; 1 g
2-Fluoro-6-O-(2-(4-nitrophenyl)ethyl)-2'-deoxyinosine	PR 3842	≥97%	25 mg;
5'-O-Dimethoxytrityl-2-fluoro-6-O-(2-(4-nitrophenyl)ethyl)-2'-deoxyinosine	PR 3843	≥90%	25 mg; 100 mg
2'-Deoxyisoguanosine	PR 3465	≥97%	10 mg; 100 mg
N6-(Diisobutylaminomethylidene)-2'-deoxyisoguanosine	PR 3510	≥90%	100 mg; 1 g
N6-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-O2-(diphenylcarbamoyl)-2'-deoxyisoguanosine	PR 3520	≥95%	100 mg; 1 g
N6-(Diisobutylaminomethylidene)-O2-(diphenylcarbamoyl)-2'-deoxyisoguanosine	PR 3530	≥90%	100 mg; 1 g
Isoguanosine	PR 3735	≥97%	10 mg; 50 mg
d5SICS	FC 8120	≥97%	25 mg; 100 mg
AICA Riboside (AICAR)	MN 20001	≥97%	0 g (DISCONTINUED);
2',3'-Di-O-methyladenosine	PR 3540	≥97%	100 mg; 1 g
2,6-Bis-O-[2-(4-nitrophenyl)ethyl]-2'-deoxyxanthosine	PR 3692	≥95%	10 mg; 100 mg
5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione	PRA 10047	≥97%	10 mg; 100 mg
8-Aza-7-deaza-2'-deoxyguanosine	PRA 10170	≥95%	10 mg; 100 mg
6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one	PRA 10175	≥95%	10 mg; 100 mg
3'-Deoxy-3',4'-didehydrocytidine	PY 7790	≥95%	10 mg; 25 mg
NPOM-Caged deoxythymidine	PY 7795	≥97%	25 mg; 100 mg
tC Nucleoside	PYA 11110	≥97%	50 mg; 100 mg
tCnitro Nucleoside	PYA 11115	≥95%	5 mg; 25 mg
2'-Deoxynebularine	PR 3470	Purity: ≥97%	100 mg; 1 g
7-Methylinosine	PR 3780	≥95%	100 mg; 250 mg
7-Methyl-6-thioguanosine	PR 3790	≥75%	25 mg; 100 mg
1-(β-D-2-Deoxyribofuranosyl)-3-nitropyrrole	PYA 11020	≥97%	50 mg;
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-3-nitropyrrole	PYA 11030	≥95%	100 mg;
Showdomycin	PYA 11056	≥97%	10 mg;
Formycin A	PYA 11001	≥97%	10 mg;
Formycin B	PYA 11002	≥97%	10 mg;
Pseudouridine	PYA 11080	≥97%	10 mg;
Pyrazofurin	PYA 11004	≥97%	10 mg;
Toyocamycin	PRA 10150	≥97%	10 mg;
7-Deazaadenosine (tubercidin)	PRA 10035	≥97%	10 mg;
Allopurinol riboside	PRA 10011	≥97%	25 mg;
5-Iodotubercidin	PRA 10095	≥90%	5 mg;
Triciribine	PRA 10160	≥97%	10 mg;
Tricyclic Nucleoside Phosphate	PRA 10162	≥95%	10 mg;
5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione	PRA 10047	≥97%	10 mg;
5'-Amino-5'-deoxythymidine	PY 7030	≥97%	25 mg; 50 mg
O2,5'-Anhydrothymidine	PY 7060	≥95%	500 mg; 1 g
3'-Azido-3'-deoxythymidine (AZT)	PY 7065	≥97%	500 mg; 1 g
5'-Azido-5'-deoxythymidine	PY 7070	≥97%	25 mg; 100 mg
3'-Azido-3'-deoxy-5'-O-methylthymidine	PY 7075	≥97%	0 g DISCONTINUED;
3'-O-(t-Butyldimethylsilyl)-5'-deoxy-5'-(1,3-diphenyl-2-imidazolidinyl)thymidine	PY 7120	≥97%	1 g;
3'-O-(t-Butyldimethylsilyl)thymidine	PY 7130	≥95%	500 mg; 1 g
5'-O-(t-Butyldimethylsilyl)thymidine	PY 7140	≥97%	5 g; 10 g
3',5'-bis-O-(t-Butyldimethylsilyl)thymidine	PY 7150	≥97%	1 g; 5 g
3',5'-bis-O-(t-Butyldimethylsilyl)-O4-(2,4,6-triisopropylphenylsulfonyl)thymidine	PY 7160	≥95%	100 mg; 500 mg
S4-(2-Cyanoethyl)-5'-O-(dimethoxytrityl)-4-thiothymidine	PY 7200	≥95%	10 mg; 100 mg
S4-(2-Cyanoethyl)-4-thiothymidine	PY 7210	≥95%	10 mg; 100 mg
5'-Deoxy-5'-(1,3-diphenyl-2-imidazolidinyl)thymidine	PY 7250	≥97%	1 g;
3'-Deoxythymidine	PY 7277	≥95%	50 mg; 100 mg
1-(3,5-Di-O-acetyl-β-D-deoxyribofuranosyl)-4-(1,2,4-triazol-1-yl)-5-methylpyrmidin-2-one	PY 7315	≥90%	1 g; 10 g
2',3'-Didehydro-3'-deoxythymidine	PY 7328	≥95%	10 mg; 100 mg
(5S)-5,6-Dihydrothymidine	PY 7340	≥97%	20 mg; 100 mg
(5S,6R)-5',6'-Cyclo-5'-deoxy-5,6-dihydrothymidine	PY 7345	≥95%	10 mg; 25 mg
(5S)-5'-O-(Dimethoxytrityl)-5,6-dihydrothymidine	PY 7390	≥97%	100 mg;
5'-O-(Dimethoxytrityl)-N3/O4-(toluoyl)-2-thiothymidine	PY 7510	≥97%	50 mg; 100 mg
2-O-Ethylthymidine	PY 7561	≥97%	500 mg; 1 g
5'-Iodo-5'-deoxythymidine	PY 7610	≥97%	250 mg; 1 g
5'-O-Methylthymidine	PY 7680	≥95%	50 mg; 100 mg
2-Thiothymidine	PY 7725	≥95%	20 mg; 100 mg
Thymidine	PY 7727	≥97%	25 g; 250 g
5'-O-(p-Toluenesulfonyl)thymidine	PY 7740	≥97%	5 g;
3-(2-Cyanoethyl)thymidine	PY 7742	≥95%	10 mg; 25 mg
5'-Trifluoroacetamido-5'-deoxythymidine	PY 7750	≥97%	50 mg;
NPOM-Caged deoxythymidine	PY 7795	≥97%	25 mg; 100 mg
6-Methyl-3-(β-D-2-deoxyribofuranosyl)furano-[2,3-d]pyrimidin-2-one	PYA 11055	≥97%	5 mg; 25 mg
6-Azathymidine	PYA 11058	≥95%	25 mg; 100 mg
NPOM-Caged-dT CEP	BA 0317	≥95%	100 µmol; 0.25 g
5-[N-(2-Aminoethyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine	PY 7040	≥97%	100 mg; 1 g
5-[N-(6-Aminohexyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine	PY 7050	≥90%	100 mg; 1 g
3'-Azido-3'-deoxy-5'-O-methylthymidine	PY 7075	≥97%	0 g DISCONTINUED;
(E)-5-(2-Carbomethoxyvinyl)-2'-deoxyuridine	PY 7170	≥97%	1 g;
(E)-5-(2-Carboxyvinyl)-2'-deoxyuridine	PY 7180	≥97%	500 mg; 1 g
(E)-5-(2-Carboxyvinyl)-2'-deoxyuridine N-Hydroxysuccinimide Ester	PY 7190	≥97%	100 mg; 1 g
(5S,6R)-5',6'-Cyclo-5'-deoxy-5,6-dihydrothymidine	PY 7345	≥95%	10 mg; 25 mg
5'-O-(Dimethoxytrityl)-5-[N-(2-(trifluoroacetamido)ethyl)-3-(E)acrylamido]-2'-deoxyuridine	PY 7520	≥97%	100 mg; 1 g
5'-O-(Dimethoxytrityl)-5-[N-(6-(trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine	PY 7530	≥97%	100 mg; 1 g
1-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-5-(2-(phthalimidooxy)ethyl)-4-(1,2,4-triazol-1-yl)-lH-pyrimidin-2-one	PY 7550	≥95%	100 mg; 1 g
3',5'-Di-O-(p-toluoyl)-5-(2-hydroxyethyl)-2'-deoxyuridine	PY 7560	≥95%	500 mg; 1 g
5-(2-Hydroxyethyl)-2'-deoxyuridine	PY 7600	≥95%	25 mg; 50 mg
3-(2-Cyanoethyl)thymidine	PY 7742	≥95%	10 mg; 25 mg
5-[3-(Trifluoroacetamido)-E-1-propenyl]-2’-deoxyuridine	PY 7754	≥95%	100 mg; 1 g
5-[N(2-(Trifluoroacetamido)ethyl)-3-(E)-acrylamido]-2'-deoxyuridine	PY 7760	≥90%	100 mg; 1 g
5-[N(6-(Trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine	PY 7770	≥95%	100 mg; 1 g
NPOM-Caged deoxythymidine	PY 7795	≥97%	25 mg; 100 mg
6-Methyl-3-(β-D-2-deoxyribofuranosyl)furano-[2,3-d]pyrimidin-2-one	PYA 11055	≥97%	5 mg; 25 mg
5-Ethynyl uridine CEP	BA 0353	≥90%	100 µmol; 0.25 g
2'-O-Acetyl-5'-O-benzoyl-5-methyl-3'-deoxyuridine	PY 7000	≥97%	500 mg; 1 g
5-[N-(2-Aminoethyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine	PY 7040	≥97%	100 mg; 1 g
5-[N-(6-Aminohexyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine	PY 7050	≥90%	100 mg; 1 g
5-(Furan-2-yl)-2'-deoxyuridine	PY 7053	≥97%	25 mg; 100 mg
1-(β-D-2-Deoxyribofuranosyl)-4-(1,2,4-triazol-1-yl)pyrimidin-2-one	PY 7055	≥97%	20 mg; 100 mg
5-Bromo-2'-deoxyuridine	PY 7117	≥97%	10 g; 25 g
5-Bromouridine	PY 7118	≥95%	5 g;
(E)-5-(2-Carbomethoxyvinyl)-2'-deoxyuridine	PY 7170	≥97%	1 g;
(E)-5-(2-Carbomethoxyvinyl)uridine	PY 7172	≥97%	25 mg; 250 mg
(E)-5-(2-Carboxyvinyl)-2'-deoxyuridine	PY 7180	≥97%	500 mg; 1 g
(E)-5-(2-Carboxyvinyl)uridine	PY 7185	≥97%	1 g;
(E)-5-(2-Carboxyvinyl)-2'-deoxyuridine N-Hydroxysuccinimide Ester	PY 7190	≥97%	100 mg; 1 g
S4-(2-Cyanoethyl)-4-thio-2'-deoxyuridine	PY 7212	≥95%	10 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-methyl-3'-deoxyuridine	PY 7240	≥95%	25 mg; 100 mg
5-Methyl-3'-deoxyuridine	PY 7260	≥95%	20 mg; 50 mg
2'-Deoxyuridine	PY 7275	≥97%	25 g; 100 g
3',5'-Di-O-acetyl-5-fluoro-2'-deoxyuridine	PY 7280	≥95%	100 mg; 500 mg
3'-Azido-2',3'-dideoxy-5-bromouridine	PY 7286	≥97%	10 mg; 50 mg
3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine	PY 7290	≥95%	500 mg; 1 g
3',5'-Di-O-acetyl-5-fluoro-2'-O-methyluridine	PY 7300	≥97%	50 mg; 250 mg
3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-deoxyuridine	PY 7310	≥97%	20 mg; 50 mg
3',5'-Di-O-benzoyl-5-fluoro-2'-O-methyluridine	PY 7320	≥97%	500 mg; 1 g
5'-O-(Dimethoxytrityl)-5-fluoro-2'-O-methyluridine	PY 7420	≥95%	100 mg; 500 mg
5'-O-(Dimethoxytrityl)-5-iodo-2'-deoxyuridine	PY 7450	≥97%	500 mg; 1 g
5'-O-(Dimethoxytrityl)-5-iodo-2'-O-methyluridine	PY 7460	≥97%	50 mg; 100 mg
5-Methoxymethyl-2'-deoxyuridine	PY 7465	≥95%	10 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-methyl-2'-O-methyluridine	PY 7470	≥97%	100 mg; 1 g
5'-O-(Dimethoxytrityl)-2'-O-methyluridine	PY 7480	≥97%	500 mg; 1 g
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-deoxyuridine	PY 7490	≥95%	50 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine	PY 7500	≥95%	25 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-[N-(2-(trifluoroacetamido)ethyl)-3-(E)acrylamido]-2'-deoxyuridine	PY 7520	≥97%	100 mg; 1 g
5'-O-(Dimethoxytrityl)-5-[N-(6-(trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine	PY 7530	≥97%	100 mg; 1 g
1-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-5-(2-(phthalimidooxy)ethyl)-4-(1,2,4-triazol-1-yl)-lH-pyrimidin-2-one	PY 7550	≥95%	100 mg; 1 g
3',5'-Di-O-(p-toluoyl)-5-(2-hydroxyethyl)-2'-deoxyuridine	PY 7560	≥95%	500 mg; 1 g
5-Ethynyl-2'-deoxyuridine	PY 7562	≥97%	25 mg; 100 mg
5-Ethynyl uridine	PY 7563	≥97%	10 mg; 100 mg
5-Fluoro-2'-deoxyuridine	PY 7565	≥97%	100 mg; 1 g
5-Fluoro-2'-O-methyluridine	PY 7570	≥97%	50 mg; 100 mg
5-Fluoro-O4-(2,4,6-trimethylphenyl)-2'-deoxyuridine	PY 7580	≥97%	25 mg; 100 mg
5-Fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine	PY 7590	≥95%	25 mg; 100 mg
5-Hydroxy-2'-deoxyuridine	PY 7597	≥95%	25 mg; 250 mg
5-(2-Hydroxyethyl)-2'-deoxyuridine	PY 7600	≥95%	25 mg; 50 mg
5-Acetoxymethyl-2'-deoxyuridine	PY 7604	≥97%	25 mg; 100 mg
5-Hydroxymethyl-2'-deoxyuridine	PY 7605	≥95%	25 mg; 250 mg
2'-Fluoro-5'-iodo deoxyuridine	PY 7612	≥95%	100 mg;
5-Iodo-2'-deoxyuridine	PY 7615	≥97%	10 g; 25 g
5-Iodo-2'-O-methyluridine	PY 7630	≥97%	100 mg; 1 g
5-Iodouridine	PY 7632	≥95%	5 g; 25 g
5-Methyl-2'-O-methyluridine	PY 7650	≥97%	100 mg; 1 g
5-(1-Propynyl)-2'-O-methyluridine	PY 7670	≥97%	10 mg; 25 mg
2'-O-Methyluridine	PY 7690	≥97%	5 g;
3-Methyluridine	PY 7694	≥97%	25 mg; 100 mg
5-Methyluridine	PY 7695	≥97%	200 mg; 1 g
5-(1-Propynyl)-2'-deoxyuridine	PY 7710	≥97%	100 mg; 1 g
5-(Propargyloxy)-2'-deoxyuridine	PY 7712	≥95%	10 mg; 100 mg
Zebularine	PY 7715	≥97%	10 mg; 25 mg
3',5'-O-(1,1,3,3-Tetraisopropyl-1,3-disiloxanediyl)-2'-deoxyuridine	PY 7720	≥90%	500 mg; 1 g
2-Thiouridine	PY 7724	≥97%	25 mg; 100 mg
5'-O-(p-Toluenesulfonyl)-2'-deoxyuridine	PY 7730	≥97%	1 g; 5 g
5-[3-(Trifluoroacetamido)-E-1-propenyl]-2’-deoxyuridine	PY 7754	≥95%	100 mg; 1 g
5-[3-(Trifluoroacetamido)-1-(E)-propenyl]uridine	PY 7758	≥97%	100 mg; 1 g
5-[N(2-(Trifluoroacetamido)ethyl)-3-(E)-acrylamido]-2'-deoxyuridine	PY 7760	≥90%	100 mg; 1 g
5-[N(6-(Trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine	PY 7770	≥95%	100 mg; 1 g
5-[N-(6-(Trifluoracetamido)hexyl)-(E)-acrylamido]uridine	PY 7775	≥97%	100 mg; 1 g
Uridine	PY 7780	≥97%	100 g; 500 g
2'3'-O-Isopropylidene uridine	PY 7781	≥97%	5 g; 25 g
5-Hydroxymethyl uridine	PY 7782	≥97%	50 mg; 100 mg
5-Methoxyuridine	PY 7783	≥97%	10 mg; 50 mg
6-Aza-2'-deoxyuridine	PYA 11057	≥95%	50 mg; 100 mg

" data-original="http://gerbu.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Berry & Associates全系列修饰核苷酸"> 艾美捷科技代理Berry & Associates全系列修饰核苷酸

...

阅读详情

Taking advantage of technologies and expertise long cultivated by the Nittobo Group, the Environment & Health Division operates a comprehensive range of business operations. In the medical field, we develop reagent for in vitro diagnostics in three fields: biochemistry, hematology, and immunology. The specialty chemicals business focuses on the development of polymer and a comprehensive range of applications. The beverage business is based on private brands and is engaged in the complete process from molding of PET bottles to manufacturing and bottling of beverages. For the green business, we sell rock wool substrate for agriculture and horticulture (made by Rockwool B.V.).

Nittobo的主要产品包括：

Textiles

Glass Fiber

Environment & Health

更多详情请联系

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

" data-original="http://gerbu.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Nittobo"> Nittobo

...

阅读详情

674 675 676 677 678 679 680 681 682 683

城市分站

友情链接 invivoCrown IV0103替换BioXCell BE0075-1 invivoCrown IV0113替换BioXCell BE0075 invivoCrown IV0121替换BioXCell BE0001-1 invivoCrown IV0117替换BioXCell BE0223 invivoCrown IV0106替换BioXCell BE0090 Calbiotech 艾美捷科技特约代理Cloud-Clone公司产品 GenWay Biotech Streck Mediomics

联系我们

地址：武汉市洪山区光谷大道35号光谷总部国际时代二期1栋1301

电话：15172469628

传真：17754422825

邮箱：sales@amyjet.com

0.3072